
The National Institute of Mental Health (NIMH), part of the National Institutes of Health, is funding five new research projects on antidepressant medications, notably selective serotonin reuptake inhibitors (SSRIs), and their association with suicidal thoughts and actions (suicidality). SSRI use in children and adolescents has become a controversial issue, with the US Food and Drug Administration (FDA), issuing a black box warning for all SSRIs in 2005.